miltefosine has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaul, DR | 1 |
| Lowe, L | 1 |
| Visvesvara, GS | 1 |
| Farmen, S | 1 |
| Khaled, YA | 1 |
| Yanik, GA | 1 |
| Verdonck, LF | 1 |
| van Heugten, HG | 1 |
2 other studies available for miltefosine and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole.
Topics: Acanthamoeba; Amebiasis; Animals; Antifungal Agents; Antiprotozoal Agents; Drug Therapy, Combination | 2008 |
Ether lipids are effective cytotoxic drugs against multidrug-resistant acute leukemia cells and can act by the induction of apoptosis.
Topics: Adult; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dr | 1997 |